Guangdong Bawei Biotechnology (BJSE:837023) EV-to-Revenue : 2.21 (As of Jun. 22, 2024)

Guangdong Bawei Biotechnology EV-to-Revenue Chart

Guangdong Bawei Biotechnology Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-Revenue		Get a 7-Day Free Trial					-	-	-	-	-

Guangdong Bawei Biotechnology Quarterly Data
	Jun17	Dec17	Mar18	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	2.99

Competitive Comparison of Guangdong Bawei Biotechnology's EV-to-Revenue

For the Household & Personal Products subindustry, Guangdong Bawei Biotechnology's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangdong Bawei Biotechnology's EV-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Bawei Biotechnology's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Guangdong Bawei Biotechnology's EV-to-Revenue falls into.

Guangdong Bawei Biotechnology EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Guangdong Bawei Biotechnology's EV-to-Revenue for today is calculated as:

Guangdong Bawei Biotechnology's current Enterprise Value is ¥1,074.4 Mil.
Guangdong Bawei Biotechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥487.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Bawei Biotechnology  (BJSE:837023) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Guangdong Bawei Biotechnology's PS Ratiofor today is calculated as:

Guangdong Bawei Biotechnology's share price for today is ¥11.57.
Guangdong Bawei Biotechnology's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.27.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Bawei Biotechnology EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Guangdong Bawei Biotechnology's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Bawei Biotechnology (BJSE:837023) Business Description